Loading...
5PSQ-058 Comparative effectiveness of regorafenib versus trifluridine/tipiracil in metastatic colorectal cancer
BACKGROUND: Regorafenib and trifluridine/tipiracil (TAS-102) are indicated in metastatic colorectal cancer (mCRC) refractary to standard therapies. Both have been approved after being compared to placebo, so comparative studies with other therapies are needed. PURPOSE: To compare effectiveness and s...
Na minha lista:
| Udgivet i: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Group
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535839/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.412 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|